November 2, 2012
Shionogi announced on October 31 that it has signed a licensing agreement with Janssen Pharmaceuticals of the US for the development of drug candidates for Alzheimer’s disease discovered by Shionogi. The compounds have a novel mechanism of action of inhibiting...read more